Fruquintinib Versus Bevacizumab Plus Chemotherapy in Second-Line RAS-Mutant Metastatic Colorectal Cancer (FRU-RAS)
Clinical trial NCT07362836 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07362836
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-31
- Primary completion
- 2028-12-30
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.